325 related articles for article (PubMed ID: 26024126)
1. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
de Sisternes L; Hu J; Rubin DL; Marmor MF
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
3. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
4. SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.
Pham BH; Marmor MF
Retina; 2019 Mar; 39(3):492-501. PubMed ID: 30550532
[TBL] [Abstract][Full Text] [Related]
5. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.
Ahn SJ; Joung J; Lim HW; Lee BR
Am J Ophthalmol; 2017 Dec; 184():11-18. PubMed ID: 28964805
[TBL] [Abstract][Full Text] [Related]
6. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
7. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
[TBL] [Abstract][Full Text] [Related]
8. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
9. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
10. Structural and Functional Characterization of the Retinal Effects of Hydroxychloroquine Treatment in Healthy Eyes.
Gil P; Nunes A; Farinha C; Teixeira D; Pires I; Silva R
Ophthalmologica; 2019; 241(4):226-233. PubMed ID: 30654376
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the outer retinal thickness pixel maps for the screening of hydroxychloroquine retinopathy.
Tarassoly K; Miraftabi A; Sedaghat A; Parvaresh MM
Int Ophthalmol; 2023 May; 43(5):1737-1743. PubMed ID: 36414851
[TBL] [Abstract][Full Text] [Related]
12. Early retinal and retinal nerve fiber layer effects of hydroxychloroquine: a follow up study by sdOCT.
Yülek F; Uğurlu N; Akçay E; Kocamış Sİ; Gerçeker S; Erten Ş; Midillioğlu İ; Şimşek Ş
Cutan Ocul Toxicol; 2013 Sep; 32(3):204-9. PubMed ID: 23351071
[TBL] [Abstract][Full Text] [Related]
13. Macular ganglion cell-inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine.
Kan E; Yakar K; Demirag MD; Gok M
Int Ophthalmol; 2018 Aug; 38(4):1635-1640. PubMed ID: 28695378
[TBL] [Abstract][Full Text] [Related]
14. Choroidal Thinning Associated With Hydroxychloroquine Retinopathy.
Ahn SJ; Ryu SJ; Joung JY; Lee BR
Am J Ophthalmol; 2017 Nov; 183():56-64. PubMed ID: 28890078
[TBL] [Abstract][Full Text] [Related]
15. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity.
Pasadhika S; Fishman GA; Choi D; Shahidi M
Eye (Lond); 2010 May; 24(5):756-62; quiz 763. PubMed ID: 20395978
[TBL] [Abstract][Full Text] [Related]
16. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
Ahn SJ; Joung J; Lee BR
Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
[TBL] [Abstract][Full Text] [Related]
17. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
Martín-Iglesias D; Artaraz J; Fonollosa A; Ugarte A; Arteagabeitia A; Ruiz-Irastorza G
Lupus; 2019 Apr; 28(4):555-559. PubMed ID: 30755141
[TBL] [Abstract][Full Text] [Related]
18. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
[TBL] [Abstract][Full Text] [Related]
20. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
Vanderzee G; Tassi D
Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
